Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
3.050
+0.010 (0.33%)
At close: Apr 18, 2024, 3:41 PM
3.010
-0.040 (-1.31%)
After-hours: Apr 18, 2024, 4:35 PM EDT
Elutia Market Cap
Elutia has a market cap or net worth of $92.79 million as of April 18, 2024. Its market cap has increased by 306.98% in one year.
Market Cap
92.79M
Enterprise Value
114.57M
1-Year Change
306.98%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $92.79M, a decrease of -46.62%. That is a compound annual growth rate of -16.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 73.80M | 6.19% |
Apr 16, 2024 | 69.50M | -1.84% |
Apr 15, 2024 | 70.80M | -2.48% |
Apr 12, 2024 | 72.60M | -1.63% |
Apr 11, 2024 | 73.80M | 6.34% |
Apr 10, 2024 | 69.40M | -0.14% |
Apr 9, 2024 | 69.50M | -5.44% |
Apr 8, 2024 | 73.50M | 1.94% |
Apr 5, 2024 | 72.10M | -3.87% |
Apr 4, 2024 | 75.00M | -2.22% |
Apr 3, 2024 | 76.70M | 2.54% |
Apr 2, 2024 | 74.80M | -0.53% |
Apr 1, 2024 | 75.20M | -1.70% |
Mar 28, 2024 | 76.50M | - |
Mar 27, 2024 | 76.50M | -2.30% |
Mar 26, 2024 | 78.30M | -1.39% |
Mar 25, 2024 | 79.40M | -0.63% |
Mar 22, 2024 | 79.90M | 2.83% |
Mar 21, 2024 | 77.70M | -3.24% |
Mar 20, 2024 | 80.30M | -2.43% |
Mar 19, 2024 | 82.30M | - |
Mar 18, 2024 | 82.30M | 2.75% |
Mar 15, 2024 | 80.10M | 1.26% |
Mar 14, 2024 | 79.10M | 8.95% |
Mar 13, 2024 | 72.60M | 5.99% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oramed Pharmaceuticals | 94.41M |
Clearside Biomedical | 94.15M |
Curis | 94.01M |
Allakos | 93.15M |
Milestone Pharmaceuticals | 93.01M |
Aurora Cannabis | 91.06M |
Armata Pharmaceuticals | 90.37M |
Reviva Pharmaceuticals Holdings | 89.34M |